Presentation on theme: "HL7-Individual Case Safety Reporting (ICSR)"— Presentation transcript:
1 HL7-Individual Case Safety Reporting (ICSR) Terminology Challenges
2 Current model encompasses reporting of drug, device and vaccines related case safety reporting capabilitiesModel build upon ICH’s E2B SpecificationsCurrently incorporating FDA and CDC’s adverse event reporting form contents: MedWatch (drug and devices adverse event reporting) and VAERS (vaccine adverse event reporting).
3 Future domains involved - Blood Products Deviations ReportingNosocomial Infection ReportingRequirements from National Patient Safety Agency, UKFood SupplementsVeterinary Products, etc.
4 Where will the uses be?Messaging will be used in several different scenarioswithin hospital systems,hospital/provider to state/local government,hospital/provider to US Federal Agencies,hospital/provider to manufacturers,hospital/provider to stakeholder agencies (NPSA, UK), andother
5 Future work will also involve- Taxonomy for Medical Errors, including near missTaxonomy of healthcare processes to answer the questions about where in the healthcare process did events and contributory factors occur.